Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data
- PMID: 34124707
- PMCID: PMC8183189
- DOI: 10.1016/j.lanepe.2021.100112
Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data
Abstract
Background: During the initial COVID-19 response, Germany's Federal Government implemented several nonpharmaceutical interventions (NPIs) that were instrumental in suppressing early exponential spread of SARS-CoV-2. NPI effect on the transmission of other respiratory viruses has not been examined at the national level thus far.
Methods: Upper respiratory tract specimens from 3580 patients with acute respiratory infection (ARI), collected within the nationwide German ARI Sentinel, underwent RT-PCR diagnostics for multiple respiratory viruses. The observation period (weeks 1-38 of 2020) included the time before, during and after a far-reaching contact ban. Detection rates for different viruses were compared to 2017-2019 sentinel data (15350 samples; week 1-38, 11823 samples).
Findings: The March 2020 contact ban, which was followed by a mask mandate, was associated with an unprecedented and sustained decline of multiple respiratory viruses. Among these, rhinovirus was the single agent that resurged to levels equalling those of previous years. Rhinovirus rebound was first observed in children, after schools and daycares had reopened. By contrast, other nonenveloped viruses (i.e. gastroenteritis viruses reported at the national level) suppressed after the shutdown did not rebound.
Interpretation: Contact restrictions with a subsequent mask mandate in spring may substantially reduce respiratory virus circulation. This reduction appears sustained for most viruses, indicating that the activity of influenza and other respiratory viruses during the subsequent winter season might be low,whereas rhinovirus resurgence, potentially driven by transmission in educational institutions in a setting of waning population immunity, might signal predominance of rhinovirus-related ARIs.
Funding: Robert Koch-Institute and German Ministry of Health.
Keywords: Nonpharmaceutical interventions; Respiratory virus; Rhinovirus; SARS-CoV-2; Surveillance.
© 2021 The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- van der Toorn W, Oh D-Y, Bourquain D, Michel J, Krause E, Nitsche A, von Kleist M. working group on SARS-CoV-2 Diagnostics at RKI. An intra-host SARS-CoV-2 dynamics model to assess testing and quarantine strategies for incoming travelers, contact person management and de-isolation. Patterns (N Y) 2021;20:100262. doi: 10.1016/j.patter.2021.100262. Epub ahead of print. PMID: 33899034; PMCID: PMC8057735. - DOI - PMC - PubMed
Further readings
-
- Takashita E, Kawakami C, Momoki T, Saikusa M, Shimizu K, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Okubo I, Morita H, Nagata S, Watanabe S, Hasegawa H, Kawaoka Y. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses. 2021 Mar 14. doi: 10.1111/irv.12854. Epub ahead of print. PMID: 33715290. - PMC - PubMed
-
- Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P, Balm M, Dobinson HC, Grant CC, James S, Aminisani N, Ralston J, Gunn W, Bocacao J, Danielewicz J, Moncrieff T, McNeill A, Lopez L, Waite B, Kiedrzynski T, Schrader H, Gray R, Cook K, Currin D, Engelbrecht C, Tapurau W, Emmerton L, Martin M, Baker MG, Taylor S, Trenholme A, Wong C, Lawrence S, McArthur C, Stanley A, Roberts S, Rahnama F, Bennett J, Mansell C, Dilcher M, Werno A, Grant J, van der Linden A, Youngblood B, Thomas PG; NPIsImpactOnFlu Consortium, Webby RJ. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021 Feb 12;12(1):1001. doi: 10.1038/s41467-021-21157-9. PMID: 33579926; PMCID: PMC7881137. - PMC - PubMed
-
- van der Toorn W, Oh DY, von Kleist M; working group on SARS-CoV-2 Diagnostics at RKI. COVIDStrategyCalculator: A software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation. Patterns (N Y). 2021 Apr 20:100264. doi: 10.1016/j.patter.2021.100264. Epub ahead of print. PMID: 33899035; PMCID: PMC8057763. - PMC - PubMed
-
- van der Toorn W, Oh D-Y, Bourquain D, et al. COVIDStrategyCalculator: a standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation. medRxiv 2020 2020.11.18.20233825.
-
- Janine Michel; Markus Neumann; Eva Krause; Thomas Rinner; Therese Muzeniek; Marica Grossegesse; Georg Hille; Franziska Schwarz; Andreas Puyskens; Sophie Förster; Barbara Biere; Daniel Bourquain; Cristina Domingo; Annika Brinkmann; Lars Schaade; Livia Schrick; Andreas Nitsche, Ph.D. Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 (2021). Virology Journal, accepted. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
